Etcembly's T-cell engager featured in Inside Precision Medicine

The announcment of Etcembly's picomolar affinity bispecific T-cell engager targeting PRAME, ETC-101, has been covered by inside Precision Medicine - Generative AI Used to Develop T Cell Cancer Immunotherapy